ARADIGM CORP Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-12-02: Reporting owner 21 APRIL FUND, L.P. | 21 APRIL FUND, LTD. | First Eagle Investment Management, LLC | First Eagle Value in Biotechnology Master Fund, Ltd.; Form 4; Security Warrants to purchase Common Stock (right to buy); Transaction P Open market or private purchase of non-derivative or derivative security.
- 2010-06-21: Reporting owner 21 APRIL FUND LTD | DEF Associates N.V. | 21 APRIL FUND LP | First Eagle Value in Biotechnology Master Fund, Ltd.; Form 4; Security Common Stock Warrants (Right to Buy); Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-12-02 | 21 APRIL FUND, L.P. | 21 APRIL FUND, LTD. | First Eagle Investment Management, LLC | First Eagle Value in Biotechnology Master Fund, Ltd. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrants to purchase Common Stock (right to buy) Derivative · Indirect · See Footnotes | P Open market or private purchase of non-derivative or derivative security | +259,117 259,117 owned after | $5.21 | 2016-12-06 | |
| 2010-06-21 | 21 APRIL FUND LTD | DEF Associates N.V. | 21 APRIL FUND LP | First Eagle Value in Biotechnology Master Fund, Ltd. | | | | 4 | Common Stock Warrants (Right to Buy) Derivative · Indirect · See Remarks, note (2). | P Open market or private purchase of non-derivative or derivative security | +4,215,239 4,215,239 owned after | $0.12 | 2010-06-22 |